The immunobiology of interleukin-27.
暂无分享,去创建一个
[1] C. Qi,et al. Elevated serum level of IL-27 and VEGF in patients with ankylosing spondylitis and associate with disease activity , 2015, Clinical and Experimental Medicine.
[2] Youhua Liu,et al. Complement Component C5a Permits the Coexistence of Pathogenic Th17 Cells and Type I IFN in Lupus , 2014, The Journal of Immunology.
[3] M. Mańczak,et al. Association of Single Nucleotide Polymorphisms in the IL27 Gene with Rheumatoid Arthritis , 2014, Scandinavian journal of immunology.
[4] L. Gapin,et al. IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization , 2014, Proceedings of the National Academy of Sciences.
[5] Yang Shen,et al. Association between interleukin-27 gene polymorphisms and susceptibility to allergic rhinitis. , 2014, Human immunology.
[6] D. Hinton,et al. IL-27 Limits Central Nervous System Viral Clearance by Promoting IL-10 and Enhances Demyelination , 2014, The Journal of Immunology.
[7] D. E. de Almeida Nagata,et al. IL-27R-mediated regulation of IL-17 controls the development of respiratory syncytial virus-associated pathogenesis. , 2014, The American journal of pathology.
[8] F. Ruemmele,et al. A Soluble Form of IL-27Rα Is a Natural IL-27 Antagonist , 2014, The Journal of Immunology.
[9] J. Schwab,et al. Timed Action of IL-27 Protects from Immunopathology while Preserving Defense in Influenza , 2014, PLoS pathogens.
[10] P. Wingfield,et al. Interleukin-35 Induces Regulatory B Cells that Suppress CNS Autoimmune Disease , 2014, Nature Medicine.
[11] S. Ferrone,et al. IL-27 in Human Secondary Lymphoid Organs Attracts Myeloid Dendritic Cells and Impairs HLA Class I–Restricted Antigen Presentation , 2014, The Journal of Immunology.
[12] F. Jin,et al. Clinical Implications of the Interleukin 27 Serum Level in Breast Cancer , 2014, Journal of Investigative Medicine.
[13] L. Eckmann,et al. Attenuation of Intestinal Inflammation in Interleukin-10-Deficient Mice Infected with Citrobacter rodentium , 2014, Infection and Immunity.
[14] Jianguo Wu,et al. IL-27, a Cytokine, and IFN-λ1, a Type III IFN, Are Coordinated To Regulate Virus Replication through Type I IFN , 2014, The Journal of Immunology.
[15] Hong Wang,et al. Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia , 2013, EMBO molecular medicine.
[16] A. Puisieux,et al. Retraction Note: Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus , 2009, Nature Immunology.
[17] M. Anver,et al. Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. , 2014, Gastroenterology.
[18] P. Ward,et al. Modulation of inflammation by interleukin‐27 , 2013, Journal of leukocyte biology.
[19] Gina Lee,et al. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer , 2013, Journal of experimental & clinical cancer research : CR.
[20] C. Lindsell,et al. Interleukin 27 as a Sepsis Diagnostic Biomarker in Critically Ill Adults , 2013, Shock.
[21] Y. Sung,et al. In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis , 2013, Experimental & Molecular Medicine.
[22] E. Zúñiga,et al. Cell-intrinsic IL-27 and gp130 cytokine receptor signaling regulates virus-specific CD4⁺ T cell responses and viral control during chronic infection. , 2013, Immunity.
[23] V. Kuchroo,et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39 , 2013, Nature Immunology.
[24] M. Pepper,et al. IL‐27 Inhibits Lymphatic Endothelial Cell Proliferation by STAT1‐Regulated Gene Expression , 2013, Microcirculation.
[25] K. Node,et al. Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice. , 2013, American journal of physiology. Heart and circulatory physiology.
[26] Xiang Gao,et al. Critical Role of Dendritic Cell–Derived IL-27 in Antitumor Immunity through Regulating the Recruitment and Activation of NK and NKT Cells , 2013, The Journal of Immunology.
[27] C. Hunter,et al. IL-21 Is Required for Optimal Antibody Production and T Cell Responses during Chronic Toxoplasma gondii Infection , 2013, PloS one.
[28] Robert M. Stephens,et al. Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties. , 2013, Biochemical and biophysical research communications.
[29] C. Hunter,et al. IL-27 Receptor Signaling Regulates CD4+ T Cell Chemotactic Responses during Infection , 2013, The Journal of Immunology.
[30] N. Yosef,et al. Metallothioneins negatively regulate IL-27–induced type 1 regulatory T-cell differentiation , 2013, Proceedings of the National Academy of Sciences.
[31] Hong Wang,et al. Synergy of IL-27 and TNF-α in regulating CXCL10 expression in lung fibroblasts. , 2013, American journal of respiratory cell and molecular biology.
[32] S. Xiong,et al. High susceptibility to liver injury in IL‐27 p28 conditional knockout mice involves intrinsic interferon‐γ dysregulation of CD4+ T cells , 2013, Hepatology.
[33] M. Batten,et al. Interleukin-27 Signaling Promotes Immunity against Endogenously Arising Murine Tumors , 2013, PloS one.
[34] D. Huang,et al. IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation , 2013, The Journal of experimental medicine.
[35] Gisen Kim,et al. A Novel Role for IL-27 in Mediating the Survival of Activated Mouse CD4 T Lymphocytes , 2013, The Journal of Immunology.
[36] Y. Tada,et al. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions. , 2013, The Journal of investigative dermatology.
[37] E. Tirotta,et al. Epstein–Barr virus-induced gene 3 negatively regulates neuroinflammation and T cell activation following coronavirus-induced encephalomyelitis , 2012, Journal of Neuroimmunology.
[38] J. Allison,et al. Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin , 2012, The Journal of experimental medicine.
[39] J. Scheller,et al. An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer* , 2012, The Journal of Biological Chemistry.
[40] H. Weiner,et al. IFN-γ Limits Th9-Mediated Autoimmune Inflammation through Dendritic Cell Modulation of IL-27 , 2012, The Journal of Immunology.
[41] H. Wong,et al. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children , 2012, Critical Care.
[42] K. Ley,et al. Interleukin-27 Receptor Limits Atherosclerosis in Ldlr−/− Mice , 2012, Circulation research.
[43] E. Pearce,et al. Persistent loss of IL-27 responsiveness in CD8+ memory T cells abrogates IL-10 expression in a recall response , 2012, Proceedings of the National Academy of Sciences.
[44] J. Ji,et al. Expression of IL-27, Th1 and Th17 in Patients with Aplastic Anemia , 2012, Journal of Clinical Immunology.
[45] D. Roos,et al. The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. , 2012, Immunity.
[46] J. Johnston,et al. Cutting Edge: Suppression of GM-CSF Expression in Murine and Human T Cells by IL-27 , 2012, The Journal of Immunology.
[47] R. Wang,et al. Novel IL27p28/IL12p40 Cytokine Suppressed Experimental Autoimmune Uveitis by Inhibiting Autoreactive Th1/Th17 Cells and Promoting Expansion of Regulatory T Cells* , 2012, The Journal of Biological Chemistry.
[48] A. Regev,et al. Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.
[49] J. Chiorini,et al. Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy , 2012, Arthritis Research & Therapy.
[50] Loise M. Francisco,et al. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1. , 2012, Immunity.
[51] H. Mühl,et al. IL-27 Regulates IL-18 Binding Protein in Skin Resident Cells , 2012, PloS one.
[52] T. Randall,et al. Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. , 2012, Immunity.
[53] J. V. Sarma,et al. Complement Activation Product C5a Is a Selective Suppressor of TLR4-Induced, but Not TLR3-Induced, Production of IL-27(p28) from Macrophages , 2012, The Journal of Immunology.
[54] Shulin Li,et al. Coordination between TLR9 Signaling in Macrophages and CD3 Signaling in T Cells Induces Robust Expression of IL-30 , 2012, The Journal of Immunology.
[55] L. Mishra,et al. Interleukin‐30: A novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine‐induced liver injury , 2012, Hepatology.
[56] C. Drake,et al. Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. , 2012, Current opinion in immunology.
[57] K. Garcia,et al. The composition and signaling of the IL-35 receptor are unconventional , 2012, Nature Immunology.
[58] D. Ribatti,et al. Interleukin-27 Inhibits the Growth of Pediatric Acute Myeloid Leukemia in NOD/SCID/Il2rg−/− Mice , 2012, Clinical Cancer Research.
[59] Vijay S. Pande,et al. Exploiting a natural conformational switch to engineer an Interleukin-2 superkine , 2012, Nature.
[60] F. Liu,et al. Influenza A Virus Induces Interleukin-27 through Cyclooxygenase-2 and Protein Kinase A Signaling* , 2012, The Journal of Biological Chemistry.
[61] Jeffrey A. Diamond,et al. STAT5 is a potent negative regulator of TFH cell differentiation , 2012, The Journal of experimental medicine.
[62] Hai Qi,et al. STAT5 Protein Negatively Regulates T Follicular Helper (Tfh) Cell Generation and Function* , 2012, The Journal of Biological Chemistry.
[63] Werner Müller,et al. IL-27 Promotes IL-10 Production by Effector Th1 CD4+ T Cells: A Critical Mechanism for Protection from Severe Immunopathology during Malaria Infection , 2012, The Journal of Immunology.
[64] Y. Liu,et al. Interleukin-27 Inhibits Vaccine-Enhanced Pulmonary Disease following Respiratory Syncytial Virus Infection by Regulating Cellular Memory Responses , 2012, Journal of Virology.
[65] H. Shen,et al. Elevated levels of interleukin-27 in patients with Sjögren's syndrome , 2012, Scandinavian journal of rheumatology.
[66] Yibing Yin,et al. IL-27 Is Elevated in Patients With COPD and Patients With Pulmonary TB and Induces Human Bronchial Epithelial Cells to Produce CXCL10 , 2012, Chest.
[67] C. Hunter,et al. The immunobiology of IL-27. , 2012, Advances in immunology.
[68] E. Zúñiga,et al. Late Interleukin-6 Escalates T Follicular Helper Cell Responses and Controls a Chronic Viral Infection , 2011, Science.
[69] S. Brand,et al. A Novel Role for Interleukin-27 (IL-27) as Mediator of Intestinal Epithelial Barrier Protection Mediated via Differential Signal Transducer and Activator of Transcription (STAT) Protein Signaling and Induction of Antibacterial and Anti-inflammatory Proteins* , 2011, The Journal of Biological Chemistry.
[70] K. Node,et al. IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice. , 2011, The American journal of pathology.
[71] A. Jafarzadeh,et al. Serum levels of interleukin (IL)-27 in patients with ischemic heart disease. , 2011, Cytokine.
[72] P. Soboslay,et al. Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria , 2011, Clinical and experimental immunology.
[73] H. Weiner,et al. IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets , 2011, PloS one.
[74] R. Kumar,et al. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. , 2011, The Journal of infectious diseases.
[75] G. Reuther,et al. Mutations in the transmembrane and juxtamembrane domains enhance IL27R transforming activity. , 2011, The Biochemical journal.
[76] Hiromu Ito,et al. IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration. , 2011, Cytokine.
[77] M. Volin,et al. Local expression of interleukin-27 ameliorates collagen-induced arthritis. , 2011, Arthritis and rheumatism.
[78] N. Tubridy,et al. IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells , 2011, Brain, Behavior, and Immunity.
[79] A. Fischer,et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis , 2011, The Journal of experimental medicine.
[80] C. Hunter,et al. A Role for IL-27 in Limiting T Regulatory Cell Populations , 2011, The Journal of Immunology.
[81] D. Ribatti,et al. Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model , 2011, Leukemia.
[82] R. Kastelein,et al. Signaling Events Involved in Interleukin 27 (IL-27)-induced Proliferation of Human Naive CD4+ T Cells and B Cells* , 2011, The Journal of Biological Chemistry.
[83] S. Takeuchi,et al. T cell‐specific overexpression of interleukin‐27 receptor α subunit (WSX‐1) prevents spontaneous skin inflammation in MRL/lpr mice , 2011, The British journal of dermatology.
[84] A. Enk,et al. IL‐27 renders DC immunosuppressive by induction of B7‐H1 , 2011, Journal of leukocyte biology.
[85] Hong Liu,et al. Interleukin-27-mediated suppression of human Th17 cells is associated with activation of STAT1 and suppressor of cytokine signaling protein 1. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[86] F. Morandi,et al. Interleukin‐27 and interleukin‐23 modulate human plasmacell functions , 2011, Journal of leukocyte biology.
[87] Changyou Wu,et al. IL-27 induces the differentiation of Tr1-like cells from human naive CD4+ T cells via the phosphorylation of STAT1 and STAT3. , 2011, Immunology letters.
[88] Shulin Li,et al. WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells , 2011, PloS one.
[89] C. Herrick,et al. EBI3 deficiency leads to diminished T helper type 1 and increased T helper type 2 mediated airway inflammation , 2011, Immunology.
[90] R. Kumar,et al. IL-27 and IL-21 Are Associated with T Cell IL-10 Responses in Human Visceral Leishmaniasis , 2011, The Journal of Immunology.
[91] Y. Hara,et al. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[92] L. Diehl,et al. IL-27 promotes T cell–dependent colitis through multiple mechanisms , 2011, The Journal of experimental medicine.
[93] E. Moser,et al. CD4+ T cell help and innate-derived IL-27 induce Blimp-1 dependent IL-10 production by anti-viral CTL , 2011, Nature Immunology.
[94] R. Schneider,et al. IL‐27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells , 2011, European journal of immunology.
[95] M. Fujimoto,et al. Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation , 2010, Annals of the rheumatic diseases.
[96] C. Lam,et al. Activation of eosinophils by IL-12 family cytokine IL-27: Implications of the pleiotropic roles of IL-27 in allergic responses. , 2011, Immunobiology.
[97] S. Tangye,et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells , 2010, The Journal of experimental medicine.
[98] G. Cheng,et al. Lipopolysaccharide-Mediated IL-10 Transcriptional Regulation Requires Sequential Induction of Type I IFNs and IL-27 in Macrophages , 2010, The Journal of Immunology.
[99] L. Ivashkiv,et al. Suppression of TNF-α and IL-1 Signaling Identifies a Mechanism of Homeostatic Regulation of Macrophages by IL-27 , 2010, The Journal of Immunology.
[100] A. Abbas,et al. STAT1-Activating Cytokines Limit Th17 Responses through Both T-bet–Dependent and –Independent Mechanisms , 2010, The Journal of Immunology.
[101] S. Chevalier,et al. IL-27 structural analysis demonstrates similarities with ciliary neurotrophic factor (CNTF) and leads to the identification of antagonistic variants , 2010, Proceedings of the National Academy of Sciences.
[102] C. Fielding,et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling , 2010, Nature Immunology.
[103] Rakesh K. Kumar,et al. IL-27/IFN-γ Induce MyD88-Dependent Steroid-Resistant Airway Hyperresponsiveness by Inhibiting Glucocorticoid Signaling in Macrophages , 2010, The Journal of Immunology.
[104] C. Hunter,et al. Essential Role for IL-27 Receptor Signaling in Prevention of Th1-Mediated Immunopathology during Malaria Infection , 2010, The Journal of Immunology.
[105] H. Weiner,et al. The Aryl hydrocarbon Receptor (AhR) interacts with c-Maf to promote the differentiation of IL-27-induced regulatory type 1 (TR1) cells , 2010, Nature Immunology.
[106] Yibing Yin,et al. Activation of human bronchial epithelial cells by inflammatory cytokines IL‐27 and TNF‐α: Implications for immunopathophysiology of airway inflammation , 2010, Journal of cellular physiology.
[107] D. Ye,et al. Low Level of Serum Interleukin 27 in Patients With Systemic Lupus Erythematosus , 2010, Journal of Investigative Medicine.
[108] Y. Shirakata,et al. Possible roles of IL-27 in the pathogenesis of psoriasis. , 2010, The Journal of investigative dermatology.
[109] C. Hunter,et al. IL-6 Promotes NK Cell Production of IL-17 during Toxoplasmosis , 2010, The Journal of Immunology.
[110] W. Ferlin,et al. The IL-27 p28 Subunit Binds Cytokine-Like Factor 1 to Form a Cytokine Regulating NK and T Cell Activities Requiring IL-6R for Signaling1 , 2009, The Journal of Immunology.
[111] Johan Van Limbergen,et al. Common variants at five new loci associated with early-onset inflammatory bowel disease , 2009, Nature Genetics.
[112] Y. Belkaid,et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. , 2009, Immunity.
[113] M. Tao,et al. IL-27 Directly Restrains Lung Tumorigenicity by Suppressing Cyclooxygenase-2-Mediated Activities1 , 2009, The Journal of Immunology.
[114] Mohamed El-behi,et al. Differential Effect of IL-27 on Developing versus Committed Th17 Cells1 , 2009, The Journal of Immunology.
[115] K. Hahm,et al. Interleukin‐27 polymorphisms are associated with inflammatory bowel diseases in a Korean population , 2009, Journal of gastroenterology and hepatology.
[116] C. Hunter,et al. IL-27 Regulates IL-10 and IL-17 from CD4+ Cells in Nonhealing Leishmania major Infection1 , 2009, The Journal of Immunology.
[117] M. Tagawa,et al. The secreted form of p28 subunit of interleukin (IL)‐27 inhibits biological functions of IL‐27 and suppresses anti‐allogeneic immune responses , 2009, Immunology.
[118] David E. Anderson,et al. IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T Cells1 , 2009, The Journal of Immunology.
[119] C. Hunter,et al. IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis1 , 2009, The Journal of Immunology.
[120] V. Kuchroo,et al. Cutting Edge: IL-27 Induces the Transcription Factor c-Maf, Cytokine IL-21, and the Costimulatory Receptor ICOS that Coordinately Act Together to Promote Differentiation of IL-10-Producing Tr1 Cells1 , 2009, The Journal of Immunology.
[121] M. Wittmann,et al. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes. , 2009, The Journal of allergy and clinical immunology.
[122] Y. Ishii,et al. Production of Both IL-27 and IFN-γ after the Treatment with a Ligand for Invariant NK T Cells Is Responsible for the Suppression of Th2 Response and Allergic Inflammation in a Mouse Experimental Asthma Model1 , 2009, The Journal of Immunology.
[123] Shulin Li,et al. Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance. , 2009, Cancer research.
[124] I. Nishimoto,et al. Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130. , 2009, Molecular biology of the cell.
[125] Zhihong Wu,et al. c-Maf Regulates IL-10 Expression during Th17 Polarization1 , 2009, The Journal of Immunology.
[126] Cristina M. Tato,et al. IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells , 2009, The Journal of Immunology.
[127] G. Trinchieri,et al. Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow1 , 2009, The Journal of Immunology.
[128] Daniel J. Campbell,et al. T-bet controls regulatory T cell homeostasis and function during type-1 inflammation , 2009, Nature Immunology.
[129] Y. Yoshikai,et al. Tumor‐specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti‐tumor immunity , 2009, International journal of cancer.
[130] K. Miyake,et al. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis , 2009, Modern rheumatology.
[131] V. Kuchroo,et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells , 2009, Nature Immunology.
[132] X. Li,et al. The pathogenic role of interleukin-27 in autoimmune diabetes , 2008, Cellular and Molecular Life Sciences.
[133] Xiao-Dong Yang,et al. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. , 2008, DNA and cell biology.
[134] G. Nau,et al. Interleukin-12 and interleukin-27 regulate macrophage control of Mycobacterium tuberculosis. , 2008, The Journal of infectious diseases.
[135] D. Hwang,et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. , 2008, Immunity.
[136] M. Shinohara,et al. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. , 2008, Immunity.
[137] C. Hunter,et al. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. , 2008, International immunology.
[138] H. Nagai,et al. Antiproliferative Activity of IL-27 on Melanoma1 , 2008, The Journal of Immunology.
[139] George D. Kalliolias,et al. IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p381 , 2008, The Journal of Immunology.
[140] Jianfei Yang,et al. Epstein‐Barr virus‐induced gene 3 negatively regulates IL‐17, IL‐22 and RORγt , 2008, European journal of immunology.
[141] Shinichi Watanabe,et al. IL‐12, IL‐23, and IL‐27 enhance human β‐defensin‐2 production in human keratinocytes , 2008, European journal of immunology.
[142] E. Riley,et al. IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.
[143] G. Cheng,et al. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. , 2008, The Journal of clinical investigation.
[144] M. Batten,et al. Cutting Edge: IL-27 Is a Potent Inducer of IL-10 but Not FoxP3 in Murine T Cells , 2008, The Journal of Immunology.
[145] H. Nakauchi,et al. Interleukin-27 directly induces differentiation in hematopoietic stem cells. , 2008, Blood.
[146] M. Huber,et al. IL-27 inhibits the development of regulatory T cells via STAT3. , 2008, International immunology.
[147] I. McInnes,et al. Interleukin 27 attenuates collagen-induced arthritis , 2008, Annals of the rheumatic diseases.
[148] S. Wittmer,et al. Cutting Edge: T-bet and IL-27R Are Critical for In Vivo IFN-γ Production by CD8 T Cells during Infection1 , 2008, The Journal of Immunology.
[149] T. Glant,et al. IL-27 Induces a Th1 Immune Response and Susceptibility to Experimental Arthritis1 , 2008, The Journal of Immunology.
[150] D. Huang,et al. IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages , 2008, AIDS.
[151] A. Yoshimura,et al. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor α (WSX-1) , 2007, Annals of the rheumatic diseases.
[152] E. Coccia,et al. IFN‐β modulates the response to TLR stimulation in human DC: Involvement of IFN regulatory factor‐1 (IRF‐1) in IL‐27 gene expression , 2007, European journal of immunology.
[153] H. Weiner,et al. A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells , 2007, Nature Immunology.
[154] Christopher A Hunter,et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 , 2007, Nature Immunology.
[155] Mohamed El-behi,et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27–stimulated T cells , 2007, Nature Immunology.
[156] K. Boyd,et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function , 2007, Nature.
[157] G. Reuther,et al. Transformation of hematopoietic cells and activation of JAK2-V617F by IL-27R, a component of a heterodimeric type I cytokine receptor , 2007, Proceedings of the National Academy of Sciences.
[158] Sen Wang,et al. Augmentation of Antigen-Presenting and Th1-Promoting Functions of Dendritic Cells by WSX-1(IL-27R) Deficiency1 , 2007, The Journal of Immunology.
[159] I. Julkunen,et al. IFN‐α regulates Toll‐like receptor‐mediated IL‐27 gene expression in human macrophages , 2007 .
[160] E. Pamer,et al. Pathogen-Specific CD8 T Cell Responses Are Directly Inhibited by IL-101 , 2007, The Journal of Immunology.
[161] K. Nakanishi,et al. IL-27 Suppresses Th2 Cell Development and Th2 Cytokines Production from Polarized Th2 Cells: A Novel Therapeutic Way for Th2-Mediated Allergic Inflammation1 , 2007, The Journal of Immunology.
[162] W. Alexander,et al. Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. , 2007, Blood.
[163] D. Fitzgerald,et al. Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.
[164] M. Neurath,et al. IL‐27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1 , 2007, European journal of immunology.
[165] M. Goldman,et al. IL-27 Synthesis Induced by TLR Ligation Critically Depends on IFN Regulatory Factor 31 , 2007, The Journal of Immunology.
[166] R. Nussenblatt,et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 , 2007, Nature Medicine.
[167] E. Goetzl,et al. Cutting Edge: Alternative Signaling of Th17 Cell Development by Sphingosine 1-Phosphate1 , 2007, The Journal of Immunology.
[168] R. Kastelein,et al. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. , 2007, Annual review of immunology.
[169] Ji Yeon Yang,et al. Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population , 2007, Journal of Human Genetics.
[170] Xiaojing Ma,et al. Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-γ–mediated pathways , 2007, The Journal of experimental medicine.
[171] Cristina M. Tato,et al. Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals , 2007, The Journal of experimental medicine.
[172] T. Yoshimoto,et al. IL-27 Induces Th1 Differentiation via p38 MAPK/T-bet- and Intercellular Adhesion Molecule-1/LFA-1/ERK1/2-Dependent Pathways1 , 2006, The Journal of Immunology.
[173] V. Boulay,et al. IL-27 induces the production of IgG1 by human B cells. , 2006, European cytokine network.
[174] L. Hennighausen,et al. Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system , 2006, Nature Immunology.
[175] V. Pascual,et al. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.
[176] K. Foulds,et al. IL-10 Is Required for Optimal CD8 T Cell Memory following Listeria monocytogenes Infection , 2006, The Journal of Immunology.
[177] D. Danilenko,et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells , 2006, Nature Immunology.
[178] H. Schild,et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27 , 2006, The Journal of experimental medicine.
[179] T. Mcclanahan,et al. IL-23 promotes tumour incidence and growth , 2006, Nature.
[180] M. Kudo,et al. Antiangiogenic and Antitumor Activities of IL-271 , 2006, The Journal of Immunology.
[181] R. Kastelein,et al. Differential Effects of IL-27 on Human B Cell Subsets1 , 2006, The Journal of Immunology.
[182] G. Freeman,et al. Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.
[183] R. Kastelein,et al. IL-27 Limits IL-2 Production during Th1 Differentiation1 , 2006, The Journal of Immunology.
[184] C. Hunter,et al. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. , 2006, The American journal of pathology.
[185] H. Nawata,et al. T Helper 1‐Inducing Property of II‐27/WSX‐1 Signaling Is Required for the Induction of Experimental Colitis , 2005, Inflammatory bowel diseases.
[186] H. Hirakata,et al. Membranous Glomerulonephritis Development with Th2-Type Immune Deviations in MRL/lpr Mice Deficient for IL-27 Receptor (WSX-1)1 , 2005, The Journal of Immunology.
[187] A. la Sala,et al. Gi-Protein-Dependent Inhibition of IL-12 Production Is Mediated by Activation of the Phosphatidylinositol 3-Kinase-Protein 3 Kinase B/Akt Pathway and JNK , 2005, The Journal of Immunology.
[188] A. Yoshimura,et al. Exacerbation of Experimental Allergic Asthma by Augmented Th2 Responses in WSX-1-Deficient Mice1 , 2005, The Journal of Immunology.
[189] T. Yoshimoto,et al. Augmentation of Effector CD8+ T Cell Generation with Enhanced Granzyme B Expression by IL-27 1 , 2005, The Journal of Immunology.
[190] M. Tagawa,et al. Expression of IL‐27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals , 2005, International journal of cancer.
[191] C. Hunter,et al. Positive and Negative Regulation of the IL-27 Receptor during Lymphoid Cell Activation1 , 2005, The Journal of Immunology.
[192] A. Suzumura,et al. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations , 2005, Brain Research.
[193] Y. Belkaid,et al. C5a negatively regulates toll-like receptor 4-induced immune responses. , 2005, Immunity.
[194] T. Mak,et al. The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis 1 , 2005, The Journal of Immunology.
[195] J. Cebon,et al. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. , 2005, Blood.
[196] R. Kastelein,et al. IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells1 , 2004, The Journal of Immunology.
[197] M. Tagawa,et al. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells. , 2004, Anticancer research.
[198] P. Lipsky,et al. Regulation of B Cell Differentiation and Plasma Cell Generation by IL-21, a Novel Inducer of Blimp-1 and Bcl-61 , 2004, The Journal of Immunology.
[199] G. Wu,et al. The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity1 , 2004, The Journal of Immunology.
[200] Y. Iwakura,et al. Induction of IgG2a Class Switching in B Cells by IL-271 , 2004, The Journal of Immunology.
[201] C. Hunter,et al. Understanding the Pro- and Anti-Inflammatory Properties of IL-271 , 2004, The Journal of Immunology.
[202] R. Grencis,et al. WSX-1: A Key Role in Induction of Chronic Intestinal Nematode Infection1 , 2004, The Journal of Immunology.
[203] C. Hunter,et al. Cutting Edge: Early IL-4 Production Governs the Requirement for IL-27-WSX-1 Signaling in the Development of Protective Th1 Cytokine Responses following Leishmania major Infection1 , 2004, The Journal of Immunology.
[204] T. Mak,et al. Hyperproduction of Proinflammatory Cytokines by WSX-1-Deficient NKT Cells in Concanavalin A-Induced Hepatitis1 , 2004, The Journal of Immunology.
[205] T. Mcclanahan,et al. WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27 , 2004, The Journal of Immunology.
[206] N. Brousse,et al. Expression of IL‐27 in human Th1‐associated granulomatous diseases , 2004, The Journal of pathology.
[207] Maria Laura Belladonna,et al. Potent Antitumor Activity of Interleukin-27 , 2004, Cancer Research.
[208] T. Mcclanahan,et al. Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.
[209] F. D. de Sauvage,et al. IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[210] T. Mak,et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. , 2003, Immunity.
[211] T. Mak,et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. , 2003, Immunity.
[212] T. Mak,et al. Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment1 , 2003, The Journal of Immunology.
[213] G. Trinchieri,et al. Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.
[214] M. Neurath,et al. Disruption of T helper 2-immune responses in Epstein–Barr virus-induced gene 3-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[215] T. Nagai,et al. Interferon-β differentially regulates expression of the IL-12 family members p35, p40, p19 and EBI3 in activated human dendritic cells , 2002, Journal of Neuroimmunology.
[216] A. Sher,et al. A Critical Role for IL-21 in Regulating Immunoglobulin Production , 2002, Science.
[217] T. Mcclanahan,et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. , 2002, Immunity.
[218] T. Mak,et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. , 2001, Immunity.
[219] F.J. Sauvage,et al. Development of Th1-type immune responses requires the type I cytokine receptor TCCR , 2000, Nature.
[220] Scott R. Presnell,et al. Cloning and characterization of a novel class I cytokine receptor. , 1998, Biochemical and biophysical research communications.
[221] E. Kieff,et al. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[222] M. Leach,et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.
[223] E. Kieff,et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes , 1996, Journal of virology.
[224] Wynn,et al. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. , 1993, The Journal of clinical investigation.